サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1178034

体外毒性検査の世界市場－方法別、技術別、最終用途別、用途別、地域別（2022年～2032年）

In-vitro Toxicology Testing Market by Method, by Technology, by End-use, by Application and by Region - 2022 to 2032
出版日: | 発行: Transparency Market Research | ページ情報: 英文 250 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
体外毒性検査の世界市場－方法別、技術別、最終用途別、用途別、地域別（2022年～2032年）
出版日: 2022年11月25日
発行: Transparency Market Research
ページ情報: 英文 250 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の体外毒性検査市場について調査分析し、市場概要、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

  • 世界市場の展望
  • 統計の要約
  • 主な市場の特徴と属性
  • 分析と推奨事項

第2章 市場概要

  • 市場範囲
  • 市場の定義

第3章 市場リスクと動向の評価

  • リスクアセスメント
    • COVID-19の危機と体外毒性検査の需要への影響
    • 過去の危機とCOVID-19no 影響ベンチマーク
    • 市場金額への影響（100万米ドル）
    • 評価：主要国別
    • 評価：主要な市場セグメント別
    • サプライヤーへのアクションポイントと推奨事項
  • 市場に影響を与える主要な動向
  • 製法と製品開発の動向

第4章 市場の背景

  • 体外毒性検査市場：主要国別
  • 体外毒性検査市場の機会評価（100万米ドル）
    • 利用可能な市場の合計
    • サービスおよびアドレス可能な市場
    • サービスおよび入手可能な市場
  • 市場シナリオ予測
    • 楽観的シナリオでの需要
    • 可能性の高いシナリオでの需要
    • 保守的シナリオでの需要
  • 投資の実現可能性分析
    • 確立された市場への投資
    • 新興市場への投資
  • 予測要因－関連性と影響
    • 主要企業の過去の成長
    • オートメーションの成長：国別
    • 体外毒性検査の採用率：国別
  • 市場力学
    • 市場の促進要因と影響評価
    • 顕著な市場課題と影響評価
    • 体外毒性検査の市場機会
    • 世界市場の顕著な動向とその影響評価

第5章 主な成功要因

  • メーカーは普及率の低い高成長市場に注力
  • セグメントを利用した銀行取引増加する高い機会
  • ピアベンチマーク

第6章 世界の体外毒性検査市場の需要分析（2017年～2021年）と予測（2022年～2032年）

  • 過去の市場分析（2017年～2021年）
  • 現在および将来の市場予測（2022年～2032年）
  • 前年比成長動向分析

第7章 世界の体外毒性検査市場の金額分析（2017年～2021年）と予測（2022年～2032年）

  • 過去の市場金額（100万米ドル）分析（2017年～2021年）
  • 現在および将来の市場金額（100万米ドル）の予測（2022年～2032年）
    • 前年比成長動向分析
    • 絶対金額機会分析

第8章 世界の体外毒性検査市場分析（2017年～2021年）と予測（2022年～2032年）：方法別

  • イントロダクション/ 主な調査結果
  • 過去の市場規模（100万米ドル）分析（2017年～2021年）：方法別
  • 現在および将来の市場規模（100万米ドル）の分析と予測（2022年～2032年）：方法別
    • 細胞アッセイ
    • 生化学的アッセイ
    • インシリコ
    • 生体外
  • 市場魅力分析：方法別

第9章 世界の体外毒性検査市場分析（2017年～2021年）と予測（2022年～2032年）：最終用途別

  • イントロダクション/ 主な調査結果
  • 過去の市場規模（100万米ドル）分析（2017年～2021年）：最終用途別
  • 現在および将来の市場規模（100万米ドル）の分析と予測（2022年～2032年）：最終用途別
    • 製薬産業
    • 化粧品・家庭用品
    • 学術機関・研究機関
    • 診断
    • 化学工業
    • 食品業界
  • 市場魅力分析：最終用途別

第10章 世界の体外毒性検査市場分析（2017年～2021年）と予測（2022年～2032年）：技術別

  • イントロダクション/ 主な調査結果
  • 過去の市場規模（100万米ドル）分析（2017年～2021年）：技術別
  • 現在および将来の市場規模（100万米ドル）の分析と予測（2022年～2032年）：技術別
    • 細胞培養技術
    • ハイスループット技術
    • 分子イメージング
    • オミックス技術
  • 市場魅力分析：技術別

第11章 世界の体外毒性検査市場分析（2017年～2021年）と予測（2022年～2032年）：用途別

  • イントロダクション/ 主な調査結果
  • 過去の市場規模（100万米ドル）分析（2017年～2021年）：用途別
  • 現在および将来の市場規模（100万米ドル）の分析と予測（2022年～2032年）：用途別
    • 全身毒性
    • 皮膚毒性
    • 内分泌かく乱
    • 眼毒性
    • その他
  • 市場魅力分析：用途別

第12章 世界の体外毒性検査市場分析（2017年～2021年）と予測（2022年～2032年）：地域別

  • イントロダクション
  • 過去の市場規模（100万米ドル）分析（2017年～2021年）：地域別
  • 現在の市場規模（100万米ドル）および分析と予測（2022年～2032年）：地域別
    • 北米
    • ラテンアメリカ
    • 欧州
    • アジア太平洋地域
    • 中東およびアフリカ
  • 市場魅力分析：地域別

第13章 北米の体外毒性検査市場分析（2017年～2021年）と予測（2022年～2032年）

第14章 ラテンアメリカの体外毒性検査市場分析（2017年～2021年）と予測（2022年～2032年）

第15章 欧州の体外毒性検査市場分析（2017年～2021年）と予測（2022年～2032年）

第16章 アジア太平洋の体外毒性検査市場分析（2017年～2021年）と予測（2022年～2032年）

第17章 中東およびアフリカの体外毒性検査市場分析（2017年～2021年）と予測（2022年～2032年）

第18章 主要国の体外毒性検査市場分析（2017年～2021年）と予測（2022年～2032年）

  • イントロダクション
  • 市場金額割合分析：主要国別
  • 世界と国の成長比較
  • 米国の体外毒性検査市場分析
  • カナダの体外毒性検査市場分析
  • メキシコの体外毒性検査市場分析
  • ブラジルの体外毒性検査市場分析
  • ドイツの体外毒性検査市場分析
  • フランスの体外毒性検査市場分析
  • イタリアの体外毒性検査市場分析
  • ベネルクス諸国の毒性検査市場分析
  • 英国の体外毒性検査市場分析
  • 北欧諸国の体外毒性検査市場分析
  • 中国の体外毒性検査市場分析
  • 日本の体外毒性検査市場分析
  • 韓国の体外毒性検査市場分析
  • GCC諸国の体外毒性検査市場分析
  • 南アフリカの体外毒性検査市場分析
  • トルコの体外毒性検査市場分析

第19章 市場構造分析

  • 市場分析：企業層別
  • 市場集中
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析
    • 地域のフットプリント：企業別
    • 製品のフットプリント：企業別

第20章 競合分析

  • 競合ダッシュボード
  • 競合のベンチマーク
  • 競合の詳細
    • MERCK KGAA
    • CHARLES RIVER
    • BIO-RAD LABORATORIES, INC.
    • ABBOTT
    • THERMO FISHER SCIENTIFIC INC.
    • CATALENT, INC.
    • GE HEALTHCARE
    • QUEST DIAGNOSTICS INCORPORATED
    • EUROFINS SCIENTIFIC
    • LABORATORY CORPORATION OF AMERICA HOLDINGS
    • EVOTEC
    • CREATIVE BIOARRAY
    • GENTRONIX
    • BIOIVT
    • SGS SA
    • AGILENT TECHNOLOGIES

第21章 使用される仮定と頭字語

第22章 調査手法

図表

List of Tables

  • Table 1: Global In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 - 2021
  • Table 2: Global In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 - 2032
  • Table 3: Global In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 - 2021
  • Table 4: Global In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 - 2032
  • Table 5: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 - 2021
  • Table 6: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 - 2032
  • Table 7: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 - 2021
  • Table 8: Global In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 - 2032
  • Table 9: Global In-vitro Toxicology Testing Market, By Region, 2017 - 2021
  • Table 10: Global In-vitro Toxicology Testing Market, By Region, 2022 - 2032
  • Table 11: North America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 - 2021
  • Table 12: North America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 - 2032
  • Table 13: North America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 - 2021
  • Table 14: North America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 - 2032
  • Table 15: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 - 2021
  • Table 16: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 - 2032
  • Table 17: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 - 2021
  • Table 18: North America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 - 2032
  • Table 19: North America In-vitro Toxicology Testing Market, By Country, 2017 - 2021
  • Table 20: North America In-vitro Toxicology Testing Market, By Country, 2022 - 2032
  • Table 21: Latin America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 - 2021
  • Table 22: Latin America In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 - 2032
  • Table 23: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 - 2021
  • Table 24: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 - 2032
  • Table 25: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 - 2021
  • Table 26: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 - 2032
  • Table 27: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 - 2021
  • Table 28: Latin America In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 - 2032
  • Table 29: Latin America In-vitro Toxicology Testing Market, By Country, 2017 - 2021
  • Table 30: Latin America In-vitro Toxicology Testing Market, By Country, 2022 - 2032
  • Table 31: Europe In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 - 2021
  • Table 32: Europe In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 - 2032
  • Table 33: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 - 2021
  • Table 34: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 - 2032
  • Table 35: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 - 2021
  • Table 36: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 - 2032
  • Table 37: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 - 2021
  • Table 38: Europe In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 - 2032
  • Table 39: Europe In-vitro Toxicology Testing Market, By Country, 2017 - 2021
  • Table 40: Europe In-vitro Toxicology Testing Market, By Country, 2022 - 2032
  • Table 41: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 - 2021
  • Table 42: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 - 2032
  • Table 43: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 - 2021
  • Table 44: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 - 2032
  • Table 45: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 - 2021
  • Table 46: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 - 2032
  • Table 47: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 - 2021
  • Table 48: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 - 2032
  • Table 49: Asia Pacific In-vitro Toxicology Testing Market, By Country, 2017 - 2021
  • Table 50: Asia Pacific In-vitro Toxicology Testing Market, By Country, 2022 - 2032
  • Table 51: MEA In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2017 - 2021
  • Table 52: MEA In-vitro Toxicology Testing Market Value (US$ Mn),By Method, 2022 - 2032
  • Table 53: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2017 - 2021
  • Table 54: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By End-use, 2022 - 2032
  • Table 55: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2017 - 2021
  • Table 56: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Technology, 2022 - 2032
  • Table 57: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2017 - 2021
  • Table 58: MEA In-vitro Toxicology Testing Market Value (US$ Mn), By Application, 2022 - 2032
  • Table 59: MEA In-vitro Toxicology Testing Market, By Country, 2017 - 2021
  • Table 60: MEA In-vitro Toxicology Testing Market, By Country, 2022 - 2032

List of Figures

  • Figure 1: Global In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
  • Figure 2: Global In-vitro Toxicology Testing Market Absolute $ Historical Gain (2017 - 2021) and Opportunity (2022 - 2032), US$ Mn
  • Figure 3: Global In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032
  • Figure 4: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method - 2022-2032
  • Figure 5: Global In-vitro Toxicology Testing Market Attractiveness Index, By Method - 2022-2032
  • Figure 6: Global In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032
  • Figure 7: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use - 2022-2032
  • Figure 8: Global In-vitro Toxicology Testing Market Attractiveness Index, By End-use - 2022-2032
  • Figure 9: Global In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032
  • Figure 10: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application - 2022-2032
  • Figure 11: Global In-vitro Toxicology Testing Market Attractiveness Index, By Application - 2022-2032
  • Figure 12: Global In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032
  • Figure 13: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology - 2022-2032
  • Figure 14: Global In-vitro Toxicology Testing Market Attractiveness Index, By Technology - 2022-2032
  • Figure 15: Global In-vitro Toxicology Testing Market Share, By Region, 2022 & 2032
  • Figure 16: Global In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Region - 2022-2032
  • Figure 17: Global In-vitro Toxicology Testing Market Attractiveness Index, By Region - 2022-2032
  • Figure 18: North America In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
  • Figure 19: North America In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 - 2032), US$ Mn
  • Figure 20: North America In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032
  • Figure 21: North America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method - 2022-2032
  • Figure 22: North America In-vitro Toxicology Testing Market Attractiveness Index, By Method - 2022-2032
  • Figure 23: North America In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032
  • Figure 24: North America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use - 2022-2032
  • Figure 25: North America In-vitro Toxicology Testing Market Attractiveness Index, By End-use - 2022-2032
  • Figure 26: North America In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032
  • Figure 27: North America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application - 2022-2032
  • Figure 28: North America In-vitro Toxicology Testing Market Attractiveness Index, By Application - 2022-2032
  • Figure 29: North America In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032
  • Figure 30: North America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology - 2022-2032
  • Figure 31: North America In-vitro Toxicology Testing Market Attractiveness Index, By Technology - 2022-2032
  • Figure 32: North America In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032
  • Figure 33: North America Market Y-o-Y Growth Projections, By Country - 2022-2032
  • Figure 34: North America Market Attractiveness Index, By Country - 2022-2032
  • Figure 35: Latin America In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
  • Figure 36: Latin America In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 - 2032), US$ Mn
  • Figure 37: Latin America In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032
  • Figure 38: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method - 2022-2032
  • Figure 39: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By Method - 2022-2032
  • Figure 40: Latin America In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032
  • Figure 41: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use - 2022-2032
  • Figure 42: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By End-use - 2022-2032
  • Figure 43: Latin America In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032
  • Figure 44: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application - 2022-2032
  • Figure 45: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By Application - 2022-2032
  • Figure 46: Latin America In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032
  • Figure 47: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology - 2022-2032
  • Figure 48: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By Technology - 2022-2032
  • Figure 49: Latin America In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032
  • Figure 50: Latin America In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Country - 2022-2032
  • Figure 51: Latin America In-vitro Toxicology Testing Market Attractiveness Index, By Country - 2022-2032
  • Figure 52: Europe In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
  • Figure 53: Europe In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 - 2032), US$ Mn
  • Figure 54: Europe In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032
  • Figure 55: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method - 2022-2032
  • Figure 56: Europe In-vitro Toxicology Testing Market Attractiveness Index, By Method - 2022-2032
  • Figure 57: Europe In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032
  • Figure 58: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use - 2022-2032
  • Figure 59: Europe In-vitro Toxicology Testing Market Attractiveness Index, By End-use - 2022-2032
  • Figure 60: Europe In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032
  • Figure 61: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application - 2022-2032
  • Figure 62: Europe In-vitro Toxicology Testing Market Attractiveness Index, By Application - 2022-2032
  • Figure 63: Europe In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032
  • Figure 64: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology - 2022-2032
  • Figure 65: Europe In-vitro Toxicology Testing Market Attractiveness Index, By Technology - 2022-2032
  • Figure 66: Europe In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032
  • Figure 67: Europe In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Country - 2022-2032
  • Figure 68: Europe In-vitro Toxicology Testing Market Attractiveness Index, By Country - 2022-2032
  • Figure 69: MEA In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
  • Figure 70: MEA In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 - 2032), US$ Mn
  • Figure 71: MEA In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032
  • Figure 72: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method - 2022-2032
  • Figure 73: MEA In-vitro Toxicology Testing Market Attractiveness Index, By Method - 2022-2032
  • Figure 74: MEA In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032
  • Figure 75: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use - 2022-2032
  • Figure 76: MEA In-vitro Toxicology Testing Market Attractiveness Index, By End-use - 2022-2032
  • Figure 77: MEA In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032
  • Figure 78: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application - 2022-2032
  • Figure 79: MEA In-vitro Toxicology Testing Market Attractiveness Index, By Application - 2022-2032
  • Figure 80: MEA In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032
  • Figure 81: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology - 2022-2032
  • Figure 82: MEA In-vitro Toxicology Testing Market Attractiveness Index, By Technology - 2022-2032
  • Figure 83: MEA In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032
  • Figure 84: MEA In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Country - 2022-2032
  • Figure 85: MEA In-vitro Toxicology Testing Market Attractiveness Index, By Country - 2022-2032
  • Figure 86: Asia Pacific In-vitro Toxicology Testing Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032
  • Figure 87: Asia Pacific In-vitro Toxicology Testing Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 - 2032), US$ Mn
  • Figure 88: Asia Pacific In-vitro Toxicology Testing Market Share, By Method, 2022 & 2032
  • Figure 89: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Method - 2022-2032
  • Figure 90: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By Method - 2022-2032
  • Figure 91: Asia Pacific In-vitro Toxicology Testing Market Share, By End-use, 2022 & 2032
  • Figure 92: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By End-use - 2022-2032
  • Figure 93: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By End-use - 2022-2032
  • Figure 94: Asia Pacific In-vitro Toxicology Testing Market Share, By Application, 2022 & 2032
  • Figure 95: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Application - 2022-2032
  • Figure 96: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By Application - 2022-2032
  • Figure 97: Asia Pacific In-vitro Toxicology Testing Market Share, By Technology, 2022 & 2032
  • Figure 98: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Technology - 2022-2032
  • Figure 99: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By Technology - 2022-2032
  • Figure 100: Asia Pacific In-vitro Toxicology Testing Market Share, By Country, 2022 & 2032
  • Figure 101: Asia Pacific In-vitro Toxicology Testing Market Y-o-Y Growth Projections, By Country - 2022-2032
  • Figure 102: Asia Pacific In-vitro Toxicology Testing Market Attractiveness Index, By Country - 2022-2032
目次
Product Code: TMRGL73510

TMR's report on the global in-vitro toxicology testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global in-vitro toxicology testing market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in-vitro toxicology testing market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the in-vitro toxicology testing market.

The report delves into the competitive landscape of the global in-vitro toxicology testing market. Key players operating in the global in-vitro toxicology testing market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global in-vitro toxicology testing market profiled in this report.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Summary of Statistics
  • 1.3. Key Market Characteristics & Attributes
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage
  • 2.2. Market Definition

3. Market Risks and Trends Assessment

  • 3.1. Risk Assessment
    • 3.1.1. COVID-19 Crisis and Impact on In-vitro Toxicology Testing Demand
    • 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
    • 3.1.3. Impact on Market Value (US$ Mn)
    • 3.1.4. Assessment by Key Countries
    • 3.1.5. Assessment by Key Market Segments
    • 3.1.6. Action Points and Recommendation for Suppliers
  • 3.2. Key Trends Impacting the Market
  • 3.3. Formulation and Product Development Trends

4. Market Background

  • 4.1. In-vitro Toxicology Testing Market, by Key Countries
  • 4.2. In-vitro Toxicology Testing Market Opportunity Assessment (US$ Mn)
    • 4.2.1. Total Available Market
    • 4.2.2. Serviceable Addressable Market
    • 4.2.3. Serviceable Obtainable Market
  • 4.3. Market Scenario Forecast
    • 4.3.1. Demand in optimistic Scenario
    • 4.3.2. Demand in Likely Scenario
    • 4.3.3. Demand in Conservative Scenario
  • 4.4. Investment Feasibility Analysis
    • 4.4.1. Investment in Established Markets
      • 4.4.1.1. In Short Term
      • 4.4.1.2. In Long Term
    • 4.4.2. Investment in Emerging Markets
      • 4.4.2.1. In Short Term
      • 4.4.2.2. In Long Term
  • 4.5. Forecast Factors - Relevance & Impact
    • 4.5.1. Top Companies Historical Growth
    • 4.5.2. Growth in Automation, By Country
    • 4.5.3. In-vitro Toxicology Testing Adoption Rate, By Country
  • 4.6. Market Dynamics
    • 4.6.1. Market Driving Factors and Impact Assessment
    • 4.6.2. Prominent Market Challenges and Impact Assessment
    • 4.6.3. In-vitro Toxicology Testing Market Opportunities
    • 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

  • 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
  • 5.2. Banking on with Segments High Incremental Opportunity
  • 5.3. Peer Benchmarking

6. Global In-vitro Toxicology Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032

  • 6.1. Historical Market Analysis, 2017-2021
  • 6.2. Current and Future Market Projections, 2022-2032
  • 6.3. Y-o-Y Growth Trend Analysis

7. Global In-vitro Toxicology Testing Market Value Analysis 2017-2021 and Forecast, 2022-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Method

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Method, 2017-2021
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Method, 2022-2032
    • 8.3.1. Cellular Assay
      • 8.3.1.1. Live Cells
      • 8.3.1.2. Fixed Cells
    • 8.3.2. Biochemical Assay
    • 8.3.3. In-Silico
    • 8.3.4. Ex-vivo
  • 8.4. Market Attractiveness Analysis By Method

9. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End-use

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By End-use, 2017-2021
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-use, 2022-2032
    • 9.3.1. Pharmaceutical Industry
    • 9.3.2. Cosmetics & Household Products
    • 9.3.3. Academic Institutes and Research Laboratories
    • 9.3.4. Diagnostics
    • 9.3.5. Chemical Industry
    • 9.3.6. Food Industry
  • 9.4. Market Attractiveness Analysis By End-use

10. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Technology

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Technology, 2017-2021
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2032
    • 10.3.1. Cell Culture Technology
    • 10.3.2. High Throughput Technology
    • 10.3.3. Molecular Imaging
    • 10.3.4. OMICS Technology
  • 10.4. Market Attractiveness Analysis By Technology

11. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Application

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Application, 2017-2021
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032
    • 11.3.1. Systemic Toxicology
    • 11.3.2. Dermal Toxicity
    • 11.3.3. Endocrine Disruption
    • 11.3.4. Occular Toxicity
    • 11.3.5. Other Applications
  • 11.4. Market Attractiveness Analysis By Application

12. Global In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
  • 12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. Asia Pacific
    • 12.3.5. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
    • 13.4.1. By Country
      • 13.4.1.1. U.S.
      • 13.4.1.2. Canada
      • 13.4.1.3. Rest of North America
    • 13.4.2. By Method
    • 13.4.3. By End-use
    • 13.4.4. By Application
    • 13.4.5. By Technology
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Method
    • 13.5.3. By End-use
    • 13.5.4. By Application
    • 13.5.5. By Technology

14. Latin America In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
    • 14.4.1. By Country
      • 14.4.1.1. Brazil
      • 14.4.1.2. Mexico
      • 14.4.1.3. Rest of Latin America
    • 14.4.2. By Method
    • 14.4.3. By End-use
    • 14.4.4. By Application
    • 14.4.5. By Technology
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Method
    • 14.5.3. By End-use
    • 14.5.4. By Application
    • 14.5.5. By Technology

15. Europe In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
    • 15.4.1. By Country
      • 15.4.1.1. Germany
      • 15.4.1.2. France
      • 15.4.1.3. U.K.
      • 15.4.1.4. Italy
      • 15.4.1.5. Benelux
      • 15.4.1.6. Nordic Countries
      • 15.4.1.7. Rest of Europe
    • 15.4.2. By Method
    • 15.4.3. By End-use
    • 15.4.4. By Application
    • 15.4.5. By Technology
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Method
    • 15.5.3. By End-use
    • 15.5.4. By Application
    • 15.5.5. By Technology

16. Asia Pacific In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
    • 16.4.1. By Country
      • 16.4.1.1. China
      • 16.4.1.2. Japan
      • 16.4.1.3. South Korea
      • 16.4.1.4. Rest of Asia Pacific
    • 16.4.2. By Method
    • 16.4.3. By End-use
    • 16.4.4. By Application
    • 16.4.5. By Technology
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Method
    • 16.5.3. By End-use
    • 16.5.4. By Application
    • 16.5.5. By Technology

17. Middle East and Africa In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
    • 17.4.1. By Country
      • 17.4.1.1. GCC Countries
      • 17.4.1.2. South Africa
      • 17.4.1.3. Turkey
      • 17.4.1.4. Rest of Middle East and Africa
    • 17.4.2. By Method
    • 17.4.3. By End-use
    • 17.4.4. By Application
    • 17.4.5. By Technology
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Method
    • 17.5.3. By End-use
    • 17.5.4. By Application
    • 17.5.5. By Technology

18. Key Countries In-vitro Toxicology Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 18.1. Introduction
    • 18.1.1. Market Value Proportion Analysis, By Key Countries
    • 18.1.2. Global Vs. Country Growth Comparison
  • 18.2. US In-vitro Toxicology Testing Market Analysis
    • 18.2.1. Value Proportion Analysis by Market Taxonomy
    • 18.2.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.2.2.1. By Method
      • 18.2.2.2. By End-use
      • 18.2.2.3. By Application
      • 18.2.2.4. By Technology
  • 18.3. Canada In-vitro Toxicology Testing Market Analysis
    • 18.3.1. Value Proportion Analysis by Market Taxonomy
    • 18.3.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.3.2.1. By Method
      • 18.3.2.2. By End-use
      • 18.3.2.3. By Application
      • 18.3.2.4. By Technology
  • 18.4. Mexico In-vitro Toxicology Testing Market Analysis
    • 18.4.1. Value Proportion Analysis by Market Taxonomy
    • 18.4.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.4.2.1. By Method
      • 18.4.2.2. By End-use
      • 18.4.2.3. By Application
      • 18.4.2.4. By Technology
  • 18.5. Brazil In-vitro Toxicology Testing Market Analysis
    • 18.5.1. Value Proportion Analysis by Market Taxonomy
    • 18.5.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.5.2.1. By Method
      • 18.5.2.2. By End-use
      • 18.5.2.3. By Application
      • 18.5.2.4. By Technology
  • 18.6. Germany In-vitro Toxicology Testing Market Analysis
    • 18.6.1. Value Proportion Analysis by Market Taxonomy
    • 18.6.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.6.2.1. By Method
      • 18.6.2.2. By End-use
      • 18.6.2.3. By Application
      • 18.6.2.4. By Technology
  • 18.7. France In-vitro Toxicology Testing Market Analysis
    • 18.7.1. Value Proportion Analysis by Market Taxonomy
    • 18.7.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.7.2.1. By Method
      • 18.7.2.2. By End-use
      • 18.7.2.3. By Application
      • 18.7.2.4. By Technology
  • 18.8. Italy In-vitro Toxicology Testing Market Analysis
    • 18.8.1. Value Proportion Analysis by Market Taxonomy
    • 18.8.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.8.2.1. By Method
      • 18.8.2.2. By End-use
      • 18.8.2.3. By Application
      • 18.8.2.4. By Technology
  • 18.9. BENELUX In-vitro Toxicology Testing Market Analysis
    • 18.9.1. Value Proportion Analysis by Market Taxonomy
    • 18.9.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.9.2.1. By Method
      • 18.9.2.2. By End-use
      • 18.9.2.3. By Application
      • 18.9.2.4. By Technology
  • 18.10. UK In-vitro Toxicology Testing Market Analysis
    • 18.10.1. Value Proportion Analysis by Market Taxonomy
    • 18.10.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.10.2.1. By Method
      • 18.10.2.2. By End-use
      • 18.10.2.3. By Application
      • 18.10.2.4. By Technology
  • 18.11. Nordic Countries In-vitro Toxicology Testing Market Analysis
    • 18.11.1. Value Proportion Analysis by Market Taxonomy
    • 18.11.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.11.2.1. By Method
      • 18.11.2.2. By End-use
      • 18.11.2.3. By Application
      • 18.11.2.4. By Technology
  • 18.12. China In-vitro Toxicology Testing Market Analysis
    • 18.12.1. Value Proportion Analysis by Market Taxonomy
    • 18.12.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.12.2.1. By Method
      • 18.12.2.2. By End-use
      • 18.12.2.3. By Application
      • 18.12.2.4. By Technology
  • 18.13. Japan In-vitro Toxicology Testing Market Analysis
    • 18.13.1. Value Proportion Analysis by Market Taxonomy
    • 18.13.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.13.2.1. By Method
      • 18.13.2.2. By End-use
      • 18.13.2.3. By Application
      • 18.13.2.4. By Technology
  • 18.14. South Korea In-vitro Toxicology Testing Market Analysis
    • 18.14.1. Value Proportion Analysis by Market Taxonomy
    • 18.14.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.14.2.1. By Method
      • 18.14.2.2. By End-use
      • 18.14.2.3. By Application
      • 18.14.2.4. By Technology
  • 18.15. GCC Countries In-vitro Toxicology Testing Market Analysis
    • 18.15.1. Value Proportion Analysis by Market Taxonomy
    • 18.15.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.15.2.1. By Method
      • 18.15.2.2. By End-use
      • 18.15.2.3. By Application
      • 18.15.2.4. By Technology
  • 18.16. South Africa In-vitro Toxicology Testing Market Analysis
    • 18.16.1. Value Proportion Analysis by Market Taxonomy
    • 18.16.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.16.2.1. By Method
      • 18.16.2.2. By End-use
      • 18.16.2.3. By Application
      • 18.16.2.4. By Technology
  • 18.17. Turkey In-vitro Toxicology Testing Market Analysis
    • 18.17.1. Value Proportion Analysis by Market Taxonomy
    • 18.17.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
      • 18.17.2.1. By Method
      • 18.17.2.2. By End-use
      • 18.17.2.3. By Application
      • 18.17.2.4. By Technology
    • 18.17.3. Competition Landscape and Player Concentration in the Country

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Concentration
  • 19.3. Market Share Analysis of Top Players
  • 19.4. Market Presence Analysis
    • 19.4.1. By Regional footprint of Players
    • 19.4.2. Product footprint by Players

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. MERCK KGAA
      • 20.3.1.1. Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Sales Footprint
      • 20.3.1.4. Strategy Overview
    • 20.3.2. CHARLES RIVER
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Sales Footprint
      • 20.3.2.4. Strategy Overview
    • 20.3.3. BIO-RAD LABORATORIES, INC.
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Sales Footprint
      • 20.3.3.4. Strategy Overview
    • 20.3.4. ABBOTT
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Sales Footprint
      • 20.3.4.4. Strategy Overview
    • 20.3.5. THERMO FISHER SCIENTIFIC INC.
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Sales Footprint
      • 20.3.5.4. Strategy Overview
    • 20.3.6. CATALENT, INC.
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Sales Footprint
      • 20.3.6.4. Strategy Overview
    • 20.3.7. GE HEALTHCARE
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Sales Footprint
      • 20.3.7.4. Strategy Overview
    • 20.3.8. QUEST DIAGNOSTICS INCORPORATED
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Sales Footprint
      • 20.3.8.4. Strategy Overview
    • 20.3.9. EUROFINS SCIENTIFIC
      • 20.3.9.1. Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Sales Footprint
      • 20.3.9.4. Strategy Overview
    • 20.3.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
      • 20.3.10.1. Overview
      • 20.3.10.2. Product Portfolio
      • 20.3.10.3. Sales Footprint
      • 20.3.10.4. Strategy Overview
    • 20.3.11. EVOTEC
      • 20.3.11.1. Overview
      • 20.3.11.2. Product Portfolio
      • 20.3.11.3. Sales Footprint
      • 20.3.11.4. Strategy Overview
    • 20.3.12. CREATIVE BIOARRAY
      • 20.3.12.1. Overview
      • 20.3.12.2. Product Portfolio
      • 20.3.12.3. Sales Footprint
      • 20.3.12.4. Strategy Overview
    • 20.3.13. GENTRONIX
      • 20.3.13.1. Overview
      • 20.3.13.2. Product Portfolio
      • 20.3.13.3. Sales Footprint
      • 20.3.13.4. Strategy Overview
    • 20.3.14. BIOIVT
      • 20.3.14.1. Overview
      • 20.3.14.2. Product Portfolio
      • 20.3.14.3. Sales Footprint
      • 20.3.14.4. Strategy Overview
    • 20.3.15. SGS SA
      • 20.3.15.1. Overview
      • 20.3.15.2. Product Portfolio
      • 20.3.15.3. Sales Footprint
      • 20.3.15.4. Strategy Overview
    • 20.3.16. AGILENT TECHNOLOGIES
      • 20.3.16.1. Overview
      • 20.3.16.2. Product Portfolio
      • 20.3.16.3. Sales Footprint
      • 20.3.16.4. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology